100 related articles for article (PubMed ID: 2261367)
1. On the receiving end--III. Measurement of quality of life during cancer chemotherapy.
Coates A; Glasziou P; McNeil D
Ann Oncol; 1990; 1(3):213-7. PubMed ID: 2261367
[TBL] [Abstract][Full Text] [Related]
2. Quality of life is improved in breast cancer patients by Standardised Mistletoe Extract PS76A2 during chemotherapy and follow-up: a randomised, placebo-controlled, double-blind, multicentre clinical trial.
Semiglazov VF; Stepula VV; Dudov A; Schnitker J; Mengs U
Anticancer Res; 2006; 26(2B):1519-29. PubMed ID: 16619567
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of quality of life scores in a trial of chemotherapy with or without interferon in patients with metastatic malignant melanoma.
Coates A; Thomson D; McLeod GR; Hersey P; Gill PG; Olver IN; Kefford R; Lowenthal RM; Beadle G; Walpole E
Eur J Cancer; 1993; 29A(12):1731-4. PubMed ID: 8398303
[TBL] [Abstract][Full Text] [Related]
4. On the receiving end. IV: Validation of quality of life indicators.
Butow P; Coates A; Dunn S; Bernhard J; Hürny C
Ann Oncol; 1991 Sep; 2(8):597-603. PubMed ID: 1793727
[TBL] [Abstract][Full Text] [Related]
5. On the receiving end--II. Linear analogue self-assessment (LASA) in evaluation of aspects of the quality of life of cancer patients receiving therapy.
Coates A; Dillenbeck CF; McNeil DR; Kaye SB; Sims K; Fox RM; Woods RL; Milton GW; Solomon J; Tattersall MH
Eur J Cancer Clin Oncol; 1983 Nov; 19(11):1633-7. PubMed ID: 6315445
[TBL] [Abstract][Full Text] [Related]
6. [The development of a new QOL Questionnaire on chemotherapy - induced emesis and vomiting--investigation of reliability and validity. Group for Investigation of QOL Questionnaire for Anti-Emetics Used in Cancer Chemotherapy. Joint Research Group for Tropisetron Double-Blind Comparative study].
Ishihara Y; Nukariya N; Kobayashi K; Yoneda S; Matsuda T; Yakushiji M; Yamakido M; Fukuoka M; Niitani H; Furue H
Gan To Kagaku Ryoho; 1996 May; 23(6):745-55. PubMed ID: 8645026
[TBL] [Abstract][Full Text] [Related]
7. [Effects of an anti-emetic tropisetron capsule on QOL of patients with delayed nausea and vomiting induced by cancer chemotherapy. Group for Investigation of QOL Questionnaire for Anti-Emetics used in Cancer Chemotherapy. Joint Research Group for Tropisetron Double-Blind Comparative Study].
Nukariya N; Kobayashi K; Ishihara Y; Yoneda S; Matsuda T; Yakushiji M; Yamakido M; Fukuoka M; Niitani H; Furue H
Gan To Kagaku Ryoho; 1996 May; 23(6):757-71. PubMed ID: 8645027
[TBL] [Abstract][Full Text] [Related]
8. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
9. Relationship of general self-efficacy with anxiety, symptom severity and quality of life in cancer patients before and after radiotherapy treatment.
Mystakidou K; Tsilika E; Parpa E; Gogou P; Panagiotou I; Vassiliou I; Gouliamos A
Psychooncology; 2013 May; 22(5):1089-95. PubMed ID: 22615047
[TBL] [Abstract][Full Text] [Related]
10. Measuring chemotherapy-induced nausea and emesis.
Martin CG; Rubenstein EB; Elting LS; Kim YJ; Osoba D
Cancer; 2003 Aug; 98(3):645-55. PubMed ID: 12879484
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of two instruments of perceived symptom intensity in palliative care patients in an outpatient clinic.
Saetra P; Fossum M; Svensson E; Cohen MZ
J Clin Nurs; 2016 Mar; 25(5-6):799-810. PubMed ID: 26813779
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of the functional assessment of cancer therapy-antiangiogenesis subscale.
Kaiser K; Beaumont JL; Webster K; Yount SE; Wagner LI; Kuzel TM; Cella D
Cancer Med; 2015 May; 4(5):690-8. PubMed ID: 25619758
[TBL] [Abstract][Full Text] [Related]
13. Validation of the Edmonton Symptom Assessment Scale.
Chang VT; Hwang SS; Feuerman M
Cancer; 2000 May; 88(9):2164-71. PubMed ID: 10813730
[TBL] [Abstract][Full Text] [Related]
14. The psychometric properties of the Turkish version of the Chemotherapy-Induced Peripheral Neuropathy Assessment Tool (CIPNAT).
Kutlutürkan S; Öztürk ES; Arıkan F; Kahraman BB; Özcan K; Uçar MA
Eur J Oncol Nurs; 2017 Dec; 31():84-89. PubMed ID: 29173832
[TBL] [Abstract][Full Text] [Related]
15. The construction and testing of the EORTC colorectal cancer-specific quality of life questionnaire module (QLQ-CR38). European Organization for Research and Treatment of Cancer Study Group on Quality of Life.
Sprangers MA; te Velde A; Aaronson NK
Eur J Cancer; 1999 Feb; 35(2):238-47. PubMed ID: 10448266
[TBL] [Abstract][Full Text] [Related]
16. [Translation and validation of a French version of the Young Mania Rating Scale (YMRS)].
Favre S; Aubry JM; Gex-Fabry M; Ragama-Pardos E; McQuillan A; Bertschy G
Encephale; 2003; 29(6):499-505. PubMed ID: 15029084
[TBL] [Abstract][Full Text] [Related]
17. Quality of life index for patients with cancer.
Padilla GV; Presant C; Grant MM; Metter G; Lipsett J; Heide F
Res Nurs Health; 1983 Sep; 6(3):117-26. PubMed ID: 6556698
[TBL] [Abstract][Full Text] [Related]
18. The use of the SF-36 questionnaire in adult survivors of childhood cancer: evaluation of data quality, score reliability, and scaling assumptions.
Reulen RC; Zeegers MP; Jenkinson C; Lancashire ER; Winter DL; Jenney ME; Hawkins MM
Health Qual Life Outcomes; 2006 Oct; 4():77. PubMed ID: 17022814
[TBL] [Abstract][Full Text] [Related]
19. Psychometric assessment of the Chinese version of the MASCC Antiemesis Tool (MAT) for measuring chemotherapy-induced nausea and vomiting.
Tan JY; Suen LK; Molassiotis A
Support Care Cancer; 2016 Sep; 24(9):3729-37. PubMed ID: 27039204
[TBL] [Abstract][Full Text] [Related]
20. Quality of life consequences of chemotherapy-induced emesis.
Lindley CM; Hirsch JD; O'Neill CV; Transau MC; Gilbert CS; Osterhaus JT
Qual Life Res; 1992 Oct; 1(5):331-40. PubMed ID: 1299465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
